Recro Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Recro Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $94,635,000. The net income raised on -$13,274,000 and profit margin reached -14%. Total operating expenses were $21,711,000.
Profit Margin
| 2014 | 0 | -16.13M | |
|---|---|---|---|
| 2015 | 51.95M | 3.03M | 5.84% |
| 2016 | 69.33M | -30.20M | -43.56% |
| 2017 | 71.83M | -50.08M | -69.72% |
| 2018 | 77.34M | -79.72M | -103.07% |
| 2019 | 99.21M | -18.63M | -18.78% |
| 2020 | 66.49M | -27.50M | -41.36% |
| 2021 | 75.36M | -26.50M | -35.17% |
| 2022 | 90.21M | -19.88M | -22.04% |
| 2023 | 94.63M | -13.27M | -14.03% |
REPH Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 94.63M | 90.21M | 75.36M | 66.49M | 99.21M | 77.34M | 71.83M | 69.33M | 51.95M | 0 |
Cost of revenue | 76.49M | 67.07M | 55.53M | 54.13M | 50.98M | 43.16M | 38.19M | 37.15M | 28.05M | 0 |
Gross profit | 18.13M | 23.13M | 19.82M | 12.36M | 48.23M | 34.18M | 33.64M | 32.18M | 23.89M | 0 |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 39.98M | 33.09M | 33.27M | 12.28M | 7.87M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 21.71M | 89.93M | 19.41M | 20.70M | 22.49M | 79.44M | 61.10M | 48.60M | 27.18M | 11.87M |
Operating income | -3.57M | -32.83M | 3.76M | -8.34M | 23.63M | -54.04M | -40.31M | -25.77M | -6.97M | -11.87M |
Other income (expenses), net | -9.56M | 14.05M | -15.13M | -19.15M | -19.00M | -8.24M | -11.64M | -5.53M | -5.54M | -4.26M |
Income before tax | -13.14M | -18.77M | -11.37M | -27.50M | 4.62M | -62.28M | -51.96M | -31.31M | -12.51M | -16.13M |
Income tax expense | 132K | 1.10M | 15.13M | 0 | 801K | 17.43M | -1.88M | -1.10M | -15.55M | 0 |
Net income | -13.27M | -19.88M | -26.50M | -27.50M | -18.63M | -79.72M | -50.08M | -30.20M | 3.03M | -16.13M |
Earnings per share | ||||||||||
Basic EPS | -0.00 | -0.34 | -0.52 | -1.16 | -0.79 | -3.9 | -2.63 | -2.82 | 0.36 | -2.59 |
Diluted EPS | -0.00 | -0.34 | -0.52 | -1.16 | -0.79 | -3.9 | -2.63 | -2.82 | 0.35 | -2.59 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |